GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ELAN · Sep 30, 2022

Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001739104-22-000017General Corporate
Debt relative to revenue94thOwn-history percentile · N=16
Evidence method

Level · gp.fundamentals.debt_to_revenue

574.03% · OPTIONAL · VALID

Capex intensity46thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.53% · OPTIONAL · VALID

Operating cash generation87thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

18.39% · OPTIONAL · VALID

Revenue growth17thOwn-history percentile · N=12
Evidence method

Yoy · gp.fundamentals.revenue

-9.11% · CORE · VALID

Inventory pressure56thOwn-history percentile · N=16
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

130.35% · OPTIONAL · VALID

Gross margin56thOwn-history percentile · N=16
Evidence method

Level · gp.fundamentals.gross_margin

54.09% · CORE · VALID

R&D intensity25thOwn-history percentile · N=16
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

7.59% · OPTIONAL · VALID

SBC intensity33thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.26% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
515.12%
Current
574.03%
Delta
58.90%
Capex Intensity Increased
Previous
2.21%
Current
2.53%
Delta
0.32%
Cash Generation Decreased
Previous
26.51%
Current
18.39%
Delta
-8.12%
Growth Decreased
Previous
-7.97%
Current
-9.11%
Delta
-1.13%
Inventory Pressure Increased
Previous
113.34%
Current
130.35%
Delta
17.01%
Margin Decreased
Previous
58.88%
Current
54.09%
Delta
-4.79%
R And D Intensity Increased
Previous
6.97%
Current
7.59%
Delta
0.62%
Sbc Intensity Decreased
Previous
1.44%
Current
1.26%
Delta
-0.18%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ELAN Fundamental State →Has State · Elanco Animal Health Inc →Transitioned To · ELAN Fundamental State →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · ELAN CAPEX_INTENSITY_INCREASED →Transitioned To · ELAN CASH_GENERATION_DECREASED →Transitioned To · ELAN GROWTH_DECREASED →Transitioned To · ELAN INVENTORY_PRESSURE_INCREASED →Transitioned To · ELAN MARGIN_DECREASED →Transitioned To · ELAN R_AND_D_INTENSITY_INCREASED →Transitioned To · ELAN SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.